The value of infectious disease conferences The Lancet Infectious Diseases ++... ++

The value of infectious disease conferences The Lancet Infectious Diseases https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00245-8/fulltext?dgcid=raven_jbs_etoc_email Jun 2026 Volume 26Number 6p549-650, e209-e267 https://www.thelancet.com/journals/laninf/issue/vol26no6/PIIS1473-3099(26)X2005-9 Case presentation of patients hospitalised with mpox (subclade Ib/2023sh) including children, adolescents, and adults in South Kivu, Democratic Republic of the Congo: an observational cohort study Luis Flores Girón, MSca,b,c,* ∙ Gustavo Sganzerla Martinez, PhDd,e,h,* ∙ Baganda Ntahuma Daniel, MDb ∙ Alfred Kesheni Bisimwa, MDb ∙ Nkonzi Pacific, MDb ∙ Georges Assumani Martin, BVSca,b,c ∙ et al. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00051-4/fulltext?dgcid=raven_jbs_etoc_feature_laninf Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial Tamiru Shibiru Degaga, MDa,b ∙ Prof Ayodhia Pitaloka Pasaribu, PhDc,d ∙ Rupam Tripura, PhDe,f ∙ Najia Ghanchi, PhDg ∙ Megha Rajasekhar, PhDh ∙ Bipin Adhikari, PhDe,f ∙ et al. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00729-7/fulltext?dgcid=raven_jbs_etoc_feature_laninf